Infinity Pharmacy debacle a $100m-plus stocking stuffer for Wesfarmers

The collapse of Infinity Pharmacy Group has highlighted the scale of creditor exposure and strategic risk for Wesfarmers, which has injected more than $100 million to support the network since acquiring Australian Pharmaceuticals Industries for $774 million, leaving major banks, private credit providers, and key suppliers facing a complex unwind constrained by pharmacy regulation, ACCC scrutiny, and limited sale options.

More from AFR (subscription required).